Stay updated on Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial page.

Latest updates to the Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial page
- Check5 days agoChange DetectedThe page displays Revision: v3.6.2, replacing the prior v3.6.0. This is a routine version update that does not modify the study details or what users see on the page.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and standardizes the Intervention/Treatment heading, plus a new revision tag (Revision: v3.6.0); older labels such as 'Verified' and 'Last known status was:' are removed.SummaryDifference1%

- Check27 days agoChange DetectedThe page's revision label was updated to v3.5.5, indicating a minor update to the entry rather than a change to study details.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page displays a new revision tag (v3.5.4) in place of the previous tag (v3.5.3), indicating a site version update rather than a change to study information.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page displays a new revision label v3.5.3, replacing the previous v3.5.2. This reflects a small update to the page version without changing its visible content.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. There are no visible changes to the study details or how users interact with the page.SummaryDifference0.1%

Stay in the know with updates to Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial page.